ALX Oncology Holdings's market cap is currently ―. The company's EPS TTM is $-3.741; its P/E ratio is -4.30; ALX Oncology Holdings is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.82. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -45.06M	$ -50.60M	$ -33.79M	$ -29.80M	$ -32.45M
EBITDA	$ -46.31M	$ -51.86M	$ -34.86M	$ -30.33M	$ -32.55M
Net Income Common Stockholders	$ -45.47M	$ -50.99M	$ -34.16M	$ -30.18M	$ -30.71M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 182.74M	$ 190.01M	$ 212.84M	$ 227.94M	$ 266.21M
Total Assets	$ 242.55M	$ 220.11M	$ 245.93M	$ 278.14M	$ 306.49M
Total Debt	$ 9.64M	$ 9.57M	$ 9.51M	$ 9.45M	$ 9.39M
Net Debt	$ -173.10M	$ -180.43M	$ -203.32M	$ -218.49M	$ -256.82M
Total Liabilities	$ 52.84M	$ 51.35M	$ 33.24M	$ 37.75M	$ 43.02M
Stockholders Equity	$ 189.71M	$ 168.75M	$ 212.69M	$ 240.39M	$ 263.46M
Cash Flow	-
Free Cash Flow	$ -39.83M	$ -29.86M	$ -33.45M	$ -28.51M	$ -21.06M
Operating Cash Flow	$ -39.68M	$ -31.16M	$ -31.71M	$ -27.82M	$ -20.67M
Investing Cash Flow	$ -16.67M	$ 12.81M	$ 6.21M	$ 42.30M	$ 10.94M
Financing Cash Flow	$ 59.17M	$ -111.00K	$ 343.00K	$ -107.00K	$ 9.49M

Currency in USD

ALX Oncology Holdings Earnings and Revenue History

Income Statement >

ALX Oncology Holdings Debt to Assets

Balance Sheet >

ALX Oncology Holdings Cash Flow

Cash Flow >

ALX Oncology Holdings Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing